The most important purpose of dyslipidemia treatment is to prevent coronary heart disease, so a comprehensive evaluation should be made based on the presence or absence of existing coronary heart disease or critical conditions such as coronary heart disease and the presence or absence of cardiovascular risk factors, combined with lipid levels, in order to decide on treatment measures and target levels of lipids. Since dyslipidemia is closely related to diet and lifestyle, dietary treatment and lifestyle improvement are the basic measures for the treatment of dyslipidemia. Dietary control and lifestyle improvement must be adhered to regardless of whether or not drug modulation therapy is administered. Depending on the type of dyslipidemia and what its treatment needs to achieve, the appropriate modulating drug should be selected. Regular monitoring of the efficacy of lipid modulation and adverse drug reactions is required. A thorough understanding of the patient’s coronary heart disease and concomitant risk factors is needed when deciding to use medications for lipid-modifying therapy. Reduction of LDL should be the primary goal when administering lipid-modifying therapy. The clinical decision to initiate pharmacologic lipid-modifying therapy and the target value to be achieved requires consideration of whether the patient has co-existing major risk factors for coronary heart disease (and risk factors other than LDL). Analysis of these major risk factors for coronary heart disease will help determine the risk of developing coronary heart disease and thus the target value for LDL reduction. The LDL levels and the LDL target values to be achieved vary considerably by risk group, depending on the drug treatment. The ideal level of serum triglycerides is 1.7 mmol/L and HDL >= 1.04 mmol/L . For specific types of dyslipidemia, such as mild to moderate elevated triglycerides (2.26-5.647 mmol/L), LDL target is still the main goal; while in severe hypertriglyceridemia (>5.657 mmol/L), triglycerides should be actively lowered first to prevent the occurrence of pancreatitis.